多模态磁共振在系统性红斑狼疮早期脑损害识别中的应用

doi:10.16138/j.1673-6087.2024.06.04

摘要/Abstract

摘要：

随着全球范围内自身免疫性疾病发病率的不断上升，系统性红斑狼疮(systemic lupus erythematosus, SLE)作为一种典型的自身免疫性疾病，其导致的脑损害日益受到关注。SLE患者脑损害发病率高且预后不良，而早期准确识别脑损害对及时干预和治疗至关重要。磁共振成像技术作为一种非侵入性影像学检查方法，可提供多模态、高分辨率的丰富数据，在SLE早期脑损害的定量研究和临床诊断评估中具有重要应用价值。本文旨在探讨多模态磁共振技术在SLE早期脑损害的机制研究和临床应用中的意义，以期为SLE患者脑损害的早期干预和治疗提供更有力的支持。

关键词: 系统性红斑狼疮, 早期脑损害, 多模态磁共振

Abstract:

With the growing number of autoimmune disorders globally, systemic lupus erythematosus (SLE), a common autoimmune disease, has received increased attention for its associated brain damage. Brain damage is common in SLE patients, and the prognosis is poor. Accurate detection of early brain damage is critical for timely diagnosis and therapy. Magnetic resonance imaging, as a non-invasive imaging technology, can provide multi-modal, high-resolution and rich data, which has good application value for quantitative research, clinical diagnosis and evaluation of early SLE brain damage. The aim of the article is to explore the role of multimodal magnetic resonance in the mechanism research and clinical diagnosis of early brain damage in SLE patients, as well as to give additional support for early intervention and treatment of brain damage.

Key words: Systemic lupus erythematosus, Early brain damage, Multimodal magnetic resonance

中图分类号:

R593.24

杨一帆, 张国芳, 徐健. 多模态磁共振在系统性红斑狼疮早期脑损害识别中的应用[J]. 内科理论与实践, 2024, 19(06): 372-378.

YANG Yifan, ZHANG Guofang, XU Jian. Application of multimodal magnetic resonance in identification of early brain damage in systemic lupus erythematosus[J]. Journal of Internal Medicine Concepts & Practice, 2024, 19(06): 372-378.

图/表 1

参考文献 37

[1]	Tsang-A-Sjoe MWP, Bultink IEM. New developments in systemic lupus erythematosus[J]. Rheumatology (Oxford), 2021, 60 Suppl 6:vi21-vi28.
[2]	Legge AC, Hanly JG. Recent advances in the diagnosis and management of neuropsychiatric lupus[J]. Nat Rev Rheumatol, 2024, 20(11): 712-728. doi: 10.1038/s41584-024-01163-z pmid: 39358609
[3]	Liu Y, Tu Z, Zhang X, et al. Pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus[J]. Front Cell Dev Biol, 2022, 10: 998328.
[4]	Carrión-Barberà I, Salman-Monte TC, Vílchez-Oya F, et al. Neuropsychiatric involvement in systemic lupus erythematosus[J]. Autoimmun Rev, 2021, 20(4):102780.
[5]	ANON. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes[J]. Arthritis Rheum, 1999, 42(4):599-608.
[6]	Schwartz N, Stock AD, Putterman C. Neuropsychiatric lupus: new mechanistic insights and future treatment directions[J]. Nat Rev Rheumatol, 2019, 15(3):137-152. doi: 10.1038/s41584-018-0156-8 pmid: 30659245
[7]	Mackay M, Tang CC, Vo A. Advanced neuroimaging in neuropsychiatric systemic lupus erythematosus[J]. Curr Opin Neurol, 2020, 33(3):353-361. doi: 10.1097/WCO.0000000000000822 pmid: 32349105
[8]	Sano E, Arawaka S. White matter hyperintensities as a risk factor for ischemic stroke in patients with systemic lupus erythematosus[J]. Front Neurol, 2021, 12:738173.
[9]	国家皮肤与免疫疾病临床医学研究中心, 中华医学会风湿病学分会, 风湿免疫病学教育部重点实验室, 等. 中国成人中枢神经精神狼疮临床实践专家共识(2024版)[J]. 中华风湿病学杂志, 2024, 28(9):613-625.
[10]	Sarbu N, Bargalló N, Cervera R. Advanced and conventional magnetic resonance imaging in neuropsychiatric lupus[J]. F1000Res, 2015, 4:162. doi: 10.12688/f1000research.6522.2 pmid: 26236469
[11]	Sarbu N, Alobeidi F, Toledano P, et al. Brain abnormalities in newly diagnosed neuropsychiatric lupus: systematic MRI approach and correlation with clinical and laboratory data in a large multicenter cohort[J]. Autoimmun Rev, 2015, 14(2):153-159. doi: 10.1016/j.autrev.2014.11.001 pmid: 25461835
[12]	Inglese F, Jaarsma-Coes MG, Steup-Beekman GM, et al. Neuropsychiatric systemic lupus erythematosus is associated with a distinct type and shape of cerebral white matter hyperintensities[J]. Rheumatology (Oxford), 2022, 61(6):2663-2671.
[13]	Idiculla PS, Gurala D, Palanisamy M, et al. Cerebral venous thrombosis: a comprehensive review[J]. Eur Neurol, 2020, 83(4):369-379.
[14]	Goto M, Abe O, Hagiwara A, et al. Advantages of using both voxel- and surface-based morphometry in cortical morphology analysis[J]. Magn Reson Med Sci, 2022, 21(1):41-57.
[15]	Cox JG, de Groot M, Cole JH, et al. A meta-analysis of structural MRI studies of the brain in systemic lupus erythematosus (SLE)[J]. Clin Rheumatol, 2023, 42(2):319-326.
[16]	Mårtensson J, Rumetshofer T, Nystedt J, et al. Structural changes on MRI demonstrate specific cerebellar involvement in SLE patients—a VBM study[J]. Brain Sci, 2021, 11(4):510.
[17]	Ni S, An N, Li C, et al. Altered structural and functional homotopic connectivity associated with cognitive changes in SLE[J]. Lupus Sci Med, 2024, 11(2):e001307.
[18]	Xu J, Cheng Y, Chai P, et al. White-matter volume reduction and the protective effect of immunosuppressive therapy in systemic lupus erythematosus patients with normal appearance by conventional magnetic resonance imaging[J]. J Rheumatol, 2010, 37(5):974-986. doi: 10.3899/jrheum.090967 pmid: 20231206
[19]	Li S, Bai R, Yang Y, et al. Abnormal cortical thickness and structural covariance networks in systemic lupus erythematosus patients without major neuropsychiatric manifestations[J]. Arthritis Res Ther, 2022, 24(1):259. doi: 10.1186/s13075-022-02954-z pmid: 36443835
[20]	Inglese F, Kant IMJ, Monahan RC, et al. Different phenotypes of neuropsychiatric systemic lupus erythematosus are related to a distinct pattern of structural changes on brain MRI[J]. Eur Radiol, 2021, 31(11):8208-8217. doi: 10.1007/s00330-021-07970-2 pmid: 33929569
[21]	Monahan RC, Inglese F, Middelkoop H, et al. White matter hyperintensities associate with cognitive slowing in patients with systemic lupus erythematosus and neuropsychiatric symptoms[J]. RMD Open, 2021, 7(2):e001650.
[22]	Zhou C, Dong M, Duan W. White matter microstructure alterations in systemic lupus erythematosus: a preliminary coordinate-based meta-analysis of diffusion tensor imaging studies[J]. Lupus, 2021, 30(12):1973-1982.
[23]	Silvagni E, Inglese F, Bortoluzzi A, et al. Longitudinal changes in cerebral white matter microstructure in newly diagnosed systemic lupus erythematosus patients[J]. Rheumatology (Oxford), 2021, 60(6):2678-2687. doi: 10.1093/rheumatology/keaa677 pmid: 33507240
[24]	Bai R, Yang Y, Liu S, et al. Impairment of white matter microstructure and structural network in patients with systemic lupus erythematosus[J]. Semin Arthritis Rheum, 2024, 71:152620.
[25]	Mackay M, Vo A, Tang CC, et al. Metabolic and microstructural alterations in the SLE brain correlate with cognitive impairment[J]. JCI Insight, 2019, 4(1):e124002.
[26]	Wang L, Han K, Huang Q, et al. Systemic lupus erythematosus-related brain abnormalities in the default mode network and the limbic system[J]. J Affect Disord, 2024, 355:190-199.
[27]	Li X, Zhang P, Zhou W, et al. Altered degree centrality in patients with non-neuropsychiatric systemic lupus erythematosus: a resting-state fMRI study[J]. J Investig Med, 2022, 70(8):1746-1752.
[28]	Mackie SL, Dejaco C, Appenzeller S, et al. British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis: executive summary[J]. Rheumatology (Oxford), 2020, 9(3):487-494.
[29]	Ma L, Yang Y, Li S, et al. Interaction of 5-HTTLPR and SLE disease status on resting-state brain function[J]. Arthritis Res Ther, 2024, 26(1):38. doi: 10.1186/s13075-024-03276-y pmid: 38297395
[30]	Frittoli RB, Pereira DR, Rittner L, et al. Proton magnetic resonance spectroscopy (1H-MRS) in rheumatic autoimmune diseases[J]. Lupus, 2020, 29(14):1873-1884. doi: 10.1177/0961203320961466 pmid: 33019878
[31]	Chi JM, Mackay M, Hoang A, et al. Alterations in blood-brain barrier permeability in patients with systemic lupus erythematosus[J]. AJNR Am J Neuroradiol, 2019, 40(3):470-477.
[32]	Kamintsky L, Beyea SD, Fisk JD, et al. Blood-brain barrier leakage in systemic lupus erythematosus is associated with gray matter loss and cognitive impairment[J]. Ann Rheum Dis, 2020, 79(12):1580-1587. doi: 10.1136/annrheumdis-2020-218004 pmid: 33004325
[33]	Wang X, Ma L, Luo Y, et al. Increasing of blood brain barrier permeability and the association with depression and anxiety in systemic lupus erythematosus patients[J]. Front Med (Lausanne), 2022, 9:852835.
[34]	Ford JN, Zhang Q, Sweeney EM, et al. Quantitative water permeability mapping of blood-brain-barrier dysfunction in aging[J]. Front Aging Neurosci, 2022, 14:867452.
[35]	Li Y, Ying Y, Yao T, et al. Decreased water exchange rate across blood-brain barrier in hereditary cerebral small vessel disease[J]. Brain, 2023, 146(7):3079-3087.
[36]	Salomonsson T, Rumetshofer T, Jönsen A, et al. Abnormal cerebral hemodynamics and blood-brain barrier permeability detected with perfusion MRI in systemic lupus erythematosus patients[J]. Neuroimage Clin, 2023, 38:103390.
[37]	Zhuo Z, Su L, Duan Y, et al. Different patterns of cerebral perfusion in SLE patients with and without neuropsychiatric manifestations[J]. Hum Brain Mapp, 2020, 41(3):755-766. doi: 10.1002/hbm.24837 pmid: 31650651